KDSK.F logo

DSM-Firmenich Stock Price

Symbol: OTCPK:KDSK.FMarket Cap: US$31.3bCategory: Materials

KDSK.F Share Price Performance

KDSK.F Community Fair Values

    Recent KDSK.F News & Updates

    No updates

    DSM-Firmenich AG Key Details

    €12.5b

    Revenue

    €9.1b

    Cost of Revenue

    €3.4b

    Gross Profit

    €3.6b

    Other Expenses

    -€190.0m

    Earnings

    Last Reported Earnings
    Jun 30, 2024
    Next Reporting Earnings
    Feb 13, 2025
    Earnings per share (EPS)
    -0.72
    Gross Margin
    27.19%
    Net Profit Margin
    -1.53%
    Debt/Equity Ratio
    20.6%

    DSM-Firmenich AG Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About KDSK.F

    Founded
    1902
    Employees
    27926
    CEO
    Dimitri de Vreeze
    WebsiteView website
    www.dsm-firmenich.com

    DSM-Firmenich AG provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. It operates through Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, cultures, hydrocolloids, proteins, natural colorants, nutritional ingredients, premixes and yeast extracts solutions. The Animal Nutrition & Health segment offers animal proteins, as well as vitamins, performance solutions, and data-driven precision services for the animal production industry. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, biomedical materials, and nutrition improvement markets. This segment offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, probiotics and prebiotics, active pharmaceutical ingredients, as well as a range of biomedical solutions; premix, market-ready solutions, and personalized nutrition solutions; and regulatory affairs and formulation expertise services, and customized solutions. The company was founded in 1902 and is based in Kaiseraugst, Switzerland.

    Swiss Market Performance

    • 7 Days: -1.2%
    • 3 Months: -1.9%
    • 1 Year: 0.6%
    • Year to Date: 2.2%
    Over the last 7 days, the market has dropped 1.2%, driven by a loss of 2.8% in the Consumer Staples sector. Although the market performance has been flat over the past year. As for the next few years, earnings are expected to grow by 11% per annum. Market details ›
    This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
    Continue reading